LOS ANGELES, Jan. 5, 2022 /PRNewswire-PRWeb/ -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products and services around the globe, announced that Waters Corporation (NYSE:WAT) is the winner of the "Overall BioPharma Innovation of the Year" award for their Waters MaxPeak™ HPS technology in the inaugural BioTech Breakthrough Awards program.
Liquid chromatography (LC) is critical for drug development and manufacturing. First introduced with its chromatography columns in 2020 and later within its ACQUITY™ Premier Liquid Chromatography (LC) Systems, Waters' MaxPeak High Performance Surface (HPS) technology is a hybrid organic/inorganic surface technology that forms a barrier between the sample and the metal surfaces of both the LC system and column.
In doing so, MaxPeak HPS technology minimizes metal-based adsorption of sample analytes, including reducing the risk of unseen analytes going undetected by 10-100X depending on the analyte, more accurate analyte identification and data interpretation, less re-work or troubleshooting, and more confidence in results. Additionally, with MaxPeak HPS technology there is no need for system passivation that wastes valuable sample material or ties up instrument time. Lastly, this innovative technology eases the reliable transfer of analytical methods from site-to-site and from company-to-company.
"We are thrilled that our technology is being recognized for solving a problem that has plagued analytical scientist for decades." said Erin Chambers Vice President, Chemistry at Waters Corporation. "Understanding first-hand the obstacles analytical scientists face in the lab when it comes to metal-analyte and other unwanted interactions, we set out to solve the problem, addressing the issue and creating an entirely new group of technologies. Now separations scientists can have greater confidence in their results, save time, improve throughput, and help bring new life-saving drugs to market faster."
The mission of the annual BioTech Breakthrough Awards program is to conduct the industry's most comprehensive analysis and evaluation of the top technology companies, solutions and products in the life sciences and biotechnology industry today. This year's program attracted more than 1,200 nominations from over 12 different countries throughout the world.
"From insulin to vaccines, LC is a core analytical technique for ensuring the safety and efficacy of medicines as required by regulatory authorities around the world. However, the interaction of transition metals with low-level analytes in drug compounds analyzed by LC, has been a persistent problem for analytical scientists," said Bryan Vaughn, Managing Director of BioTech Breakthrough Awards. "The Waters MaxPeak HPS technology is the true solution to unwanted interactions with metal chromatography instrument components and columns. We offer our sincere congratulations to Waters Corporation for winning the 'Overall BioPharma Innovation of the Year' award."
####
About BioTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the BioTech Breakthrough Awards program is devoted to honoring excellence in life science and biotechnology solutions, services and companies. The BioTech Breakthrough Awards provide public recognition for the achievements of biotechnology companies and products in categories including BioPharma, Genomics, Therapeutics, Food Science and BioAgriculture, and more. For more information visit BioTechBreakthroughawards.com
Media Contact
Bryan Vaughn, BioTech Breakthrough Awards, 949.529.4120, [email protected]
Chris Orlando, Waters Corporation, 508.482.2623, [email protected]
SOURCE BioTech Breakthrough Awards
Share this article